P4-129: Alzheimer's disease: Molecular mechanism of anesthetics induced ABETA peptide oligomerization using spectroscopy

2006 ◽  
Vol 2 ◽  
pp. S553-S554
Author(s):  
Pravat K. Mandal ◽  
Jay W. Pettegrew ◽  
K. Panchalingam ◽  
Ratna Mandal
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Molecular Mechanism ◽  
Abeta Peptide

Molecular Mechanism of Amyloidogenicity and Neurotoxicity of a Pro-aggregated Tau Mutant in the Presence of Histidine Tautomerism via Replica-Exchange Simulation.

2021 ◽  
Author(s):  
Sompriya Chatterjee ◽  
Abbas Salimi ◽  
Jin Yong Lee
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Molecular Mechanism ◽  
Replica Exchange

The accumulation of ΔK280 tau mutant resulting in neurotoxic oligomeric aggregates is an important but yet mysterious procedure in Alzheimer’s disease (AD) development. Recently, we proposed a histidine tautomerization hypothesis...

P3-275: Abeta-oligomer selective antibody A-887755 exhibits a favorable profile for Alzheimer's disease immunotherapy compared to Abeta-peptide unselective antibodies

2009 ◽  
Vol 5 (4S_Part_14) ◽  
pp. P424-P424 ◽  
Author(s):  
Stefan Barghorn ◽  
Andreas Striebinger ◽  
Simone Giaisi ◽  
Anika Koehler ◽  
Ulrich Ebert ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Abeta Peptide

A comparative study of EPA-enriched ethanolamine plasmalogen and EPA-enriched phosphatidylethanolamine on Aβ42 induced cognitive deficiency in a rat model of Alzheimer's disease

2018 ◽  
Vol 9 (5) ◽  
pp. 3008-3017 ◽  
Author(s):  
Hongxia Che ◽  
Qian Li ◽  
Tiantian Zhang ◽  
Lin Ding ◽  
Lingyu Zhang ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Comparative Study ◽  
Molecular Mechanism ◽  
Rat Model ◽  
Model Of Alzheimer’S Disease ◽  
Ethanolamine Plasmalogen ◽  
Cognitive Deficiency

The possible molecular mechanism of EPA-pPE and EPA-PE on AD.

Sign in / Sign up

Export Citation Format

Share Document